sftd

Allegra® Oral Suspension, USFDA-approved for Treatment of Seasonal Allergy Symptoms and Chronic Idiopathic Urticaria in Pediatric Patients

Filed in archive Treatment on October 20, 2006

Allegra® Oral Suspension, USFDA-approved for Treatment of Seasonal Allergy Symptoms and Chronic Idiopathic Urticaria in Pediatric Patients
Allegra® (fexofenadine hydrochloride) Oral Suspension (full prescribing information, a pdf file) for the twice-daily treatment of symptoms associated with seasonal allergies in pediatric patients (2 to 11 years of age) and for the treatment of chronic idiopathic urticaria in children 6 months to 11 years of age has recently been approved by the USFDA.

Allegra® Oral Suspension from Sanofi-aventis (U.S.) is a good tasting, easy-to-swallow formulation antihistamine for children without the cognitively impairing adverse side effects.

Allegra does not cause sedation at any dose.

Allergizer has a similar entry.

Source: Sanofi-Aventis (a pdf file)

Permalink: Allegra® Oral Suspension, USFDA-approved for Treatment of Seasonal Allergy Symptoms and Chronic Idiopathic Urticaria in Pediatric Patients

Tags: Allegra®  Oral  Suspension  seasonal  allergy  antihistamine  allergic  rhinits    oral  oral+suspension 

 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Allergies   Alzheimer's Disease   Arthritis   Bacteria and Bacterial Infections   Best of   Blog Carnivals   Bone Health   Cancer   Cardiovascular Health   Cases   CFS   Consumer Alert   Controversies   Dental Health   Diabetes   Diagnostics   Diarrhea   Did you know   Diet   Dietary Supplements and Vitamins